Management and outcome of patients with definite, probable and possible tuberculous meningitis (n = 120).

TB, tuberculosis; n, number of patients; N, number of patients for whom results were available; IQR, interquartile range; LP, lumbar puncture; ART, antiretroviral therapy; TBM, tuberculous meningitis; D4T, stavudine 30 mg twice daily; 3TC, lamivudine 150 mg twice daily or 300 mg daily; EFV, efavirenz 600 mg nightly; AZT, zidovudine 300 mg twice daily; tenofovir 300 mg daily.
**Significantly more patients with definite TBM (71%) received corticosteroid treatment compared to patients with possible TBM (32%, p<0.01).
1N includes patients not on TB treatment at presentation.
2N includes HIV-infected patients not on ART at presentation who survived admission. Treatment regimens included: 1) D4T, 3TC, EFV (n = 14) 2) AZT, 3TC, EFV (n = 7) 3) 3TC, TDF, EFV (n = 3). Treatment regimes were not known for 7 patients.
3Outcomes reported for all patients (n = 120) with TBM.
4Only including patients who died during hospitalization.